Related references
Note: Only part of the references are listed.Sirolimus and tuberous sclerosis-associated renal angiomyolipomas
L. Krischock et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2010)
Sirolimus in renal transplant recipients with tuberous sclerosis complex: clinical effectiveness and implications for innate immunity
Michael Haidinger et al.
TRANSPLANT INTERNATIONAL (2010)
Rapamycin as a Therapy of Choice After Renal Transplantation in a Patient With Tuberous Sclerosis Complex
A. Tarasewicz et al.
TRANSPLANTATION PROCEEDINGS (2009)
Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment
Judith M. Morton et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis
D. Mark Davies et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
John J. Bissler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis
Elahna Paul et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex
Isabelle Herry et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2007)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex
Ralf Wienecke et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Efficacy of a rapamycin analog (CCI-779) and IFN-γ in tuberous sclerosis mouse models
L Lee et al.
GENES CHROMOSOMES & CANCER (2005)
Effects of rapamycin in the Eker rat model of tuberous sclerosis complex
H Kenerson et al.
PEDIATRIC RESEARCH (2005)
Share Paper
